Dr. Scott A. Waldman obtained his PhD degree from Thomas Jefferson University and his MD degree from Stanford University in Stanford, CA. He was a fellow at Stanford University in the laboratory of Dr. Ferid Murad. He is currently the Samuel MV Hamilton Professor of Medicine and Chair of Pharmacology, Physiology, and Cancer Biology at Thomas Jefferson University. He is a member of numerous professional boards and editor of numerous peer-reviewed journals. He has mentored dozens of junior faculty, post-doctoral fellows, and students. He is the author of hundreds of papers, and more than 100 patents/applications. His work has formed the basis for three companies, all with assets in clinical development. His research focuses on novel diagnostic, prevention, and therapeutic strategies for patients with cancer, obesity, or neurodegenerative diseases.
Dr. Scott A. Waldman obtained his PhD degree from Thomas Jefferson University and his MD degree from Stanford University in Stanford, CA. He was a fellow at Stanford University in the laboratory of Dr. Ferid Murad. He is currently the Samuel MV Hamilton Professor of Medicine and Chair of Pharmacology, Physiology, and Cancer Biology at Thomas Jefferson University. He is a member of numerous professional boards and editor of numerous peer-reviewed journals. He has mentored dozens of junior faculty, post-doctoral fellows, and students. He is the author of hundreds of papers, and more than 100 patents/applications. His work has formed the basis for three companies, all with assets in clinical development. His research focuses on novel diagnostic, prevention, and therapeutic strategies for patients with cancer, obesity, or neurodegenerative diseases.